In ERα-negative breast cancer cells, adiponectin, activating AMPK/ACC, inhibits fatty acid synthesis, while in ERα-positive breast cancer cells it isn’t able to modify this process [139,141]. The gene discussed is ADIPOQ; the disease is breast cancer.